Dementia Clinical Trials

Find Dementia Clinical Trials Near You

Efficacy and Mechanisms of a Metacognitive Strategy Intervention for Parkinson Disease-Related Cognitive Decline.

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Mild cognitive decline is common in early Parkinson disease (PD) and is associated with disability, reduced quality of life (QOL), and increased risk for dementia. Medical treatments for PD do not prevent or treat cognitive decline and may even exacerbate the problem. Unfortunately, existing cognitive interventions for PD, which focus on restoring deficient cognitive skills through cognitive training (repetitive practice of tasks that challenge specific cognitive skills), provide limited benefit for daily function and QOL. To overcome this limitation, the investigators use strategy training. the investigators help people develop targeted strategies to use in everyday life to circumvent cognitive deficits and accomplish daily activities. Contemporary cognitive rehabilitation evidence supports strategy training for other neurological conditions and mild cognitive impairment (MCI), but it has not been well-studied in PD. By teaching strategies for everyday cognition, the investigators hypothesize that our interventions will improve functional outcomes for people with PD. Study participants will complete a baseline cognitive testing session, 10 cognitive treatment sessions with a trained occupational therapist, then have follow-up visits with the study team at 1-week, 3-months, 6-months, and 12-months after completing the study intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Males and females over age 50 who meet criteria for typical idiopathic PD.

• Hoehn \& Yahr stage I-III.

• Have subjective cognitive decline (SCD) as defined by a positive answer to either question:

‣ Do you feel like your thinking skills or memory are becoming worse or are worse than others your age?

⁃ Do you have problems or concerns with your thinking skills or memory?, and can list ≥1 daily cognitive challenge they want to address.

• Medications should be stable for 4 weeks prior with no changes planned during the treatment portion of the study (Pre to Post); unplanned changes and changes over the follow-up period will be tracked and accounted for as appropriate.

Locations
United States
Missouri
Washington University School of Medicine
RECRUITING
St Louis
Contact Information
Primary
Tasha D Doty, MA
tdoty@wustl.edu
785-865-8943
Backup
Erin Foster, PhD
erfoster@wustl.edu
314-286-1638
Time Frame
Start Date: 2026-05-20
Estimated Completion Date: 2030-08-31
Participants
Target number of participants: 114
Treatments
Experimental: MC Approach
The experimental Multicontext Approach Intervention
Active_comparator: Process Training
The Control Group cognitive process training
Experimental: MC + Booster
From the MC Approach group only, MC+Boster participants will receive 2 additional treatment sessions with their original OT within the month following their 6mo FU assessment.
Sponsors
Leads: Washington University School of Medicine

This content was sourced from clinicaltrials.gov